Nao Yoshida1, Kenichiro Watanabe2, Asahito Hama1, Shohei Yamamoto3, Maiko Noguchi4, Yoji Sasahara5, Hirotoshi Sakaguchi1, Yoshiko Hashii6, Atsushi Sato7, Yoshiko Atsuta8, Daiichiro Hasegawa9
(1.Department of Pediatric Hematology and Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 2.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan, 3.Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan, 4.Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 5.Department of Pediatrics, Tohoku University Hospital, Sendai, Japan, 6.Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan, 7.Department of Hematology and Oncology, Miyagi Children’s Hospital, Sendai, Japan, 8.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 9.Department of Hematology and Oncology, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan)
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.